Capital Advisors Wealth Management, LLC Aldeyra Therapeutics, Inc. Transaction History
Capital Advisors Wealth Management, LLC
- $681 Million
- Q3 2025
A detailed history of Capital Advisors Wealth Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Capital Advisors Wealth Management, LLC holds 10,800 shares of ALDX stock, worth $52,920. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,800
Previous 10,800
-0.0%
Holding current value
$52,920
Previous $41,000
34.15%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ALDX
# of Institutions
133Shares Held
34.9MCall Options Held
244KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$26.8 Million14.27% of portfolio
-
Perceptive Advisors LLC New York, NY4.05MShares$19.9 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$17.2 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT2.05MShares$10 Million1.29% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $286M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...